Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 3 - Caught on Camera

3 Dividend Stocks With 100+ Years of History and Sky-High Growth

These three century-old companies boast strong buy ratings, 50%+ dividend growth, and rock-solid fundamentals—ideal picks for long-term income investors.

Barchart

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield

Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.

MarketBeat

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but dialed back earnings and growth projections for the rest of the year.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year.

Benzinga

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.

Benzinga

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories (NYSE:ABT) will release earnings results for the second quarter, before the opening bell on Thursday, July 17.

Benzinga

Always Sunny In Philadelphia's Gang Was Back At Their Worst In The Abbott Elementary Crossover, But Quinta Brunson Shocked Me With The Biggest Spit Take Moment

Quinta Brunson's Janine vs. Kaitlin Olson's Dee!

Cinemablend

Read news from The Economist, FT, and more,
with one subscription

Quinta Brunson: Abbott Elementary cast would 'love to pursue other projects'

Quinta Brunson feels "blessed" that Abbott Elementary is still popular but admitted she's looking forward to a different role in the future.

BANG Premier

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

Barchart

What to Expect From Abbott Laboratories' Q2 2025 Earnings Report

Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth.

Barchart

3 Dividend Growth Stocks To Buy and Hold Forever

These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.

Barchart

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

Discover 3 Dividend Aristocrats with high earnings growth, low payout ratios, and strong analyst ratings: perfect for long-term income investors.

Barchart

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

The 3 Most Powerful Dividend Kings You’ve Probably Overlooked

These three Dividend Kings have strong cash flow and EPS growth, making a compelling case for long-term income investors.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

Barchart

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

These three Dividend Kings are beating the market in 2025, offering strong yields, reliable growth, and solid analyst buy ratings.

RideApart

MotoAmerica Revolutionises Rapid Concussion Testing in Sport With New Blood Test

The last time a helmet saved my life, I certainly wasn't feeling right for some time. I was dizzy, to say the least, but did I have a concussion? I don't know, and that's a problem in motorcycle racing. I continued to ride that day, but if I'd had Abbott's…

Get all your
news in one place.

100's of premium titles.
One news app.

Sports Illustrated

2025 Boston Marathon: Sharon Lokedi Shatters Course Record in Dominant Win

Lokedi broke the course record with a time of 2:17:22.

MarketBeat

Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.

TechRadar

Abbott Elementary is Hulu's #3 most-watched show – here are 3 more comedies with over 90% on Rotten Tomatoes to stream

It's nearly the end of term for Abbott Elementary season 4, but school's in for these three comedies.

Barchart

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Homes & Gardens

Jake Arnold's L.A.-meets-London outdoor collection with Crate & Barrel is giving me the motivation to springboard my new season patio makeover

When the inspo is this good, you want to buy into it immediately

Fortune

Nearly 20 infant formulas found to contain toxic lead, arsenic, or both. Here's how parents can keep babies safe

“We really want these results to be empowering for parents,” said Consumer Reports, which tested 41 types of baby formula.

Barchart

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.